These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9514242)

  • 1. Conformational analysis of the highly potent bradykinin antagonist Hoe-140 by means of two different computational methods.
    Filizola M; Centeno NB; Cartení-Farina M; Perez JJ
    J Biomol Struct Dyn; 1998 Feb; 15(4):639-52. PubMed ID: 9514242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
    Sikorska Trzepałka E; Slusarz R; Lammek B
    J Biomol Struct Dyn; 2005 Oct; 23(2):125-34. PubMed ID: 16060686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the conformational domains of bradykinin by computational methods.
    Perez JJ; Sanchez YM; Centeno NB
    J Pept Sci; 1995; 1(4):227-35. PubMed ID: 9223000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization, and conformational analysis of the D/L-Tic7 stereoisomers of the bradykinin receptor antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin.
    Sawutz DG; Salvino JM; Seoane PR; Douty BD; Houck WT; Bobko MA; Doleman MS; Dolle RE; Wolfe HR
    Biochemistry; 1994 Mar; 33(9):2373-9. PubMed ID: 8117696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
    Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
    J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
    Otter A; Bigler P; Stewart JM; Kotovych G
    Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the N-terminal beta-turn in bradykinin antagonists.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threonine6-bradykinin: molecular dynamics simulations in a biphasic membrane mimetic.
    Pellegrini M; Mierke DF
    J Med Chem; 1997 Jan; 40(1):99-104. PubMed ID: 9016333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aggregation properties of some bradykinin analogs.
    Liu X; Stewart JM; Cann JR; Gera L; Kotovych G
    J Biomol Struct Dyn; 1993 Aug; 11(1):169-79. PubMed ID: 8216942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance studies of bradykinin antagonists.
    Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of the bradykinin receptor as determined by computer simulations, mutagenesis experiments, and conformationally constrained ligands: establishing the framework for the design of new antagonists.
    Kyle DJ
    Braz J Med Biol Res; 1994 Aug; 27(8):1757-79. PubMed ID: 7749367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conformation-activity relations of des-Arg9-bradykinin. I. Conformation of molecules in solution].
    Shenderovich MD
    Bioorg Khim; 1989 Sep; 15(9):1173-84. PubMed ID: 2590252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system.
    Mavunkel BJ; Lu Z; Goehring RR; Lu S; Chakravarty S; Perumattam J; Novotny EA; Connolly M; Valentine H; Kyle DJ
    J Med Chem; 1996 Aug; 39(16):3169-73. PubMed ID: 8759638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine6-bradykinin: structural characterization in the presence of micelles by nuclear magnetic resonance and distance geometry.
    Pellegrini M; Mammi S; Peggion E; Mierke DF
    J Med Chem; 1997 Jan; 40(1):92-8. PubMed ID: 9016332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides.
    Kyle DJ; Martin JA; Burch RM; Carter JP; Lu S; Meeker S; Prosser JC; Sullivan JP; Togo J; Noronha-Blob L
    Agents Actions Suppl; 1992; 38 ( Pt 1)():513-25. PubMed ID: 1334629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nmr and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lyso phosphatidylcholine micelles.
    Young JK; Hicks RP
    Biopolymers; 1994 May; 34(5):611-23. PubMed ID: 8003621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas-phase basicities for ions from bradykinin and its des-arginine analogues.
    Ewing NP; Pallante GA; Zhang X; Cassady CJ
    J Mass Spectrom; 2001 Aug; 36(8):875-81. PubMed ID: 11523086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR and simulated annealing investigations of bradykinin in presence of polyphenols.
    Richard T; Vergé S; Berké B; Vercauteren J; Monti JP
    J Biomol Struct Dyn; 2001 Feb; 18(4):627-37. PubMed ID: 11245257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.